Aleurites moluccana and its main active ingredient, the flavonoid 2″-O-rhamnosylswertisin, have promising antinociceptive effects in experimental models of hypersensitivity in mice

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 2, 2012, Pages 302-311

  Quintão, Nara L M ^a   Antonialli, Carla S ^a   Da Silva, Gislaine F ^a   Rocha, Lilian W ^a   De Souza, Márcia M ^a   Malheiros, Angela ^a   Meyre Silva, Christiane ^a   Lucinda Silva, Ruth M ^a   Bresolin, Tania M B ^a   Filho, Valdir Cechinel ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

2 O rhamnosylswertisin; Aleurites moluccana; Inflammatory pain; Natural product; Neuropathic pain

Indexed keywords

2'' O RHAMNOSYLSWERTISIN; ALEURITES MOLUCCANA EXTRACT; CARRAGEENAN; FLAVONOID; FREUND ADJUVANT; GABAPENTIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALEURITES MOLUCCANA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; FEMALE; HEAT SENSITIVITY; HYPERSENSITIVITY; INFLAMMATION; MEDICINAL PLANT; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; SINGLE DRUG DOSE;

ALEURITES; ANALGESICS; ANIMALS; FEMALE; FLAVONES; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; PAIN; PEROXIDASE; RHAMNOSE;

ALEURITES MOLUCCANA; ANIMALIA; MUS;

EID: 84861583944     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.05.005     Document Type: Article

References (43)

1. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010;229(1-2):26-50.
2. Bortolanza LB, Ferreira J, Hess SC, Delle Monache F, Yunes RA, Calixto JB. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur J Pharmacol 2002;453(2-3):203-8.
3. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007;105(1):205-21.
4. Campos CR, Ocheltree SM, Hom S, Egleton RD, Davis TP. Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res 2008;1221:6-13.
5. Corrêa PM. Dicionário das plantas úteis do Brasil e das exóticas cultivadas, vol.: 5. Rio de Janeiro: Imprensa Nacional Rio de Janeiro; 1984. p. 294-5.
6. Coyle DE, Selhorst CS, Mascari C. Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model. Neurosci Lett 1995;186:135-8.
7. Cunha TM, Verri Jr WA, Silva JS, Poole S, Cunha FQ, Ferreira SH. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A 2005;102(5):1755-60.
8. Cunha TM, Verri Jr WA, Schivo IR, Napimoga MH, Parada CA, Poole S, et al. Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 2008;83(4):824-32.
9. da Cunha FM, Duma D, Assreuy J, Buzzi FC, Niero R, Campos MM, et al. Caffeic acid derivatives: in vitro and in vivo anti-inflammatory properties. Free Radic Res 2004;38(11):1241-53.
10. Duke JA. Handbook of medicinal herbs. Boca Raton: CRC Press; 1990.
11. Dunham NW, Miya TS. A note on a simple apparatus for detecting neurobiological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 1957;46:208-9.
12. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118(3):289-305.
13. Hashmi JA, Yashpal K, Holdsworth DW, Henry JL. Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam. Inflamm Res 2010;59(8):667-78.
14. Holden JE, Pizzi JA. The challenge of chronic pain. Adv Drug Deliv Rev 2003;55(8):935-48.
15. Kim HK, Kim JH, Gao X, Zhou JL, Lee I, Chung K, et al. Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain. Pain 2006;122(1-2):53-62.
16. Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry 2009;31(3):206-19.
17. Kuboyama K, Tsuda M, Tsutsui M, Toyohara Y, Tozaki-Saitoh H, Shimokawa H, et al. Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases. Mol Pain 2011;7:50.
18. Li CY, Zhang XL, Matthews EA, Li KW, Kurwa A, Boroujerdi A, et al. Calcium channel alpha(2) delta(1) subunit mediates spinal hyperexcitability in pain modulation. Pain 2006;125:20-34.
19. Lima MA, Trad LA. The medical perspective towards chronic pain: biomedical model and clinical practice. Cad Saude Publica 2007;23(11):2672-80.
20. Locher CP, Witvrouw M, Béthune M, Burch MT, Mower HF, Davis H, et al. Antiviral activity of Hawaiian medicinal plants against human immunodeficiency virus type-1 (HIV-1). Phytomedicine 1996;2:259-64.
21. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 1998;76(1-2):215-22.
22. McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR, et al. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem 2008;106(6):2395-409.
23. McCleane G, Smith HS. Opioids for persistent noncancer pain. Anesthesiol Clin 2007;25(4):787-807.
24. Meyre-Silva C, Mora TC, Santos ARS, Dal Magro J, Yunes RA, Cechinel-Filho V. Preliminary phytochemical and pharmacological studies of Aleurites moluccana leaves (L.) Willd. Phytomedicine 1998;5(2):109-13.
25. Meyre-Silva C, Yunes RA, Santos ARS, Dal Magro J, Delle-Maonache F, Cechinel-Filho V. Isolation of C-glycoside flavonoid with antinociceptive action from Aleurites moluccana leaves. Planta Med 1999;65:293-4.
26. Millan MJ. Descending control of pain. Prog Neurobiol 2002;66(6):355-474.
27. Morlion B. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Curr Med Res Opin 2011;27(1):11-33.
28. Munro G. Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test. Eur J Pharmacol 2007;575(1-3):66-74.
29. Naik AK, Tandan SK, Kumar D, Dudhgaonkar SP. Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats. Eur J Pharmacol 2006;530(1-2):59-69.
30. Pedrosa RC, Meyre-Silva C, Cechinel-Filho V, Benassi JC, Oliveira FL, Zancanaro V, et al. Hypolipidaemic activity of methanolic extract of Aleurites moluccana. Phytother Res 2002;16:765-8.
31. Potvin S, Grignon S, Marchand S. Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 2009;63(5):390-402.
32. Quintão NLM, Medeiros R, Santos ARS, Campos MM, Calixto JB. Effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice. Anesth Analg 2005;101(6):1763-9.
33. Quintão NLM, Meyre-Silva C, Silva GF, Antonialli CS, Rocha LW, Lucinda-Silva RM, et al. Aleurites moluccana (L.) Willd. leaves: mechanical antinociceptive properties of a standardized dried extract and its chemical markers. Evid Based Complement Alternat Med 2011:1-10.
34. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al. Interleukin- 1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410(6827):471-5.
35. Sarkis R, Saadé N, Atweh S, Jabbur S, Al-Amin H. Chronic dizocilpine or apomorphine and development of neuropathy in two rat models I: behavioral effects and role of nucleus accumbens. Exp Neurol 2011;228(1):19-29.
36. Toth C, Lander J, Wiebe S. The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med 2009;10(5):918-29.
37. Tseng KY, O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 2004;24(22):5131-9.
38. Turk DC, Okifuji A. Pain terms and taxonomies of pain. In: Fishman SM, Ballantyne JC, Rathmell JP, editors. Bonica's management of pain. 4th edn. New York, NY, USA: Lippincott Williams & Wilkins; 2009. p. 13-23.
39. Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet 2011;377(9784):2226-35.
40. Wood PB. Mesolimbic dopaminergic mechanisms and pain control. Pain 2006;120(3):230-4.
41. Woolf CJ. What is this thing called pain? J Clin Invest 2010;120(11):3742-4.
42. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288(5472):1765-9.
43. Woolfe G, MacDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther 1944;80:300-7.